0001062993-14-006903.txt : 20141125 0001062993-14-006903.hdr.sgml : 20141125 20141125165618 ACCESSION NUMBER: 0001062993-14-006903 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141121 FILED AS OF DATE: 20141125 DATE AS OF CHANGE: 20141125 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Toby CENTRAL INDEX KEY: 0001405128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 141250305 MAIL ADDRESS: STREET 1: 4092 BOCAIRE BLVD. CITY: BOCA RATON STATE: FL ZIP: 33487 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2014-11-21 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001405128 Wegman Toby C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2014-11-21 4 M 0 15000 17 A 16714 D Common Stock, $0.001 par value 2014-11-21 4 S 0 10000 39.0369 D 6714 D Common Stock, $0.001 par value 2014-11-24 4 S 0 2050 39.2590 D 4664 D Stock Option (Right to Buy) 17 2014-11-21 4 M 0 15000 0 D 2018-06-24 Common Stock, $0.001 par value 15000 0 D The selling price of $39.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.00 to $39.10. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The selling price of $39.2590 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $39.25 to $39.62. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. The options vested monthly with respect to 1/12 of the total number of shares until all shares underlying the option fully vested. /s/Toby Wegman by Carl A. Valenstein, attorney- in-fact 2014-11-25